Michelle is an integrative psychotherapeutic counsellor in private practice, based in London. She has been a member of Imperial college’s psychedelic research team since 2015. Michelle was a lead guide on the Imperial College’s most recent RCT trial which is comparing psilocybin to anti-depressants as a form of treatment for depression. (Psilodep2)
Currently she is working on a DMT trial as the lead therapist looking at the efficacy of DMT to treat depression a collaborative trial between Small Pharma and Imperial College.
Michelle offers individual psychedelic integration for people who are struggling to process psychedelic experiences and co – facilitates two monthly Psychedelic Integration groups